21.06.2022 - LONDON, June 21, 2022 (GLOBE NEWSWIRE) - Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company was named the winner of the .